PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

General OA media and info, page-654

  1. 628 Posts.
    lightbulb Created with Sketch. 114
    I tried to purchase the related report 'Sprifermin Emerging Drug Insight and Market Forecast - 2032' but it seems to costs thousands!

    I note two things already which give me hope.

    I read in the link that their injection is intra-articular (into the joint), whereas ours is subcutaneous (under the skin) which I recall Mozz saying is the more comfortable option. (That's right, yes, Mozz?) I didn't see how many injections are required so that could be a deal breaker if results are similar.
    Retreatment is required every 6-12 months, more frequently than ours, again in our favour.

    I think there has been discussion about Sprifermin before on this platform. If anyone remembers where I can find it, I would appreciate your help.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $211.2K 895.4K

Buyers (Bids)

No. Vol. Price($)
4 82174 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 49300 8
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.